When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
The FDA approves Deciphera Pharmaceuticals' (DCPH+6.7%) ripretinib, branded as Qinlock, for the fourth-line treatment of gastrointestinal stromal tumor (GIST).
More news on: Deciphera Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,